Cervantes González, Alba
Belbin, Olivia http://orcid.org/0000-0002-6109-6371
Funding for this research was provided by:
Instituto de Salud Carlos III (PI18/00327)
Agència de Gestió d’Ajuts Universitaris i de Recerca (2019 PROD 000088)
Article History
Received: 3 December 2021
Accepted: 20 January 2022
First Online: 11 February 2022
Declarations
:
: Dr Belbin is inventor of a patent application (EP18382175) pending approval entitled “Markers of synaptopathy in neurodegenerative disease”.